학력

• 1998.03 ~ 2002.02     성균관대학교   약학부   약학사
• 2002.03 ~ 2009.08     서울대학교      약학과   약학박사

최근 연구업적

• RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse, JOURNAL OF CLINICAL INVESTIGATION, VOL.131(1)(2021), AMER SOC CLINICAL INVESTIGATION INC, 2021.01.04
• ​The ATF6-EGF Pathway Mediates the Awakening of Slow-Cycling Chemoresistant Cells and Tumor Recurrence by Stimulating Tumor Angiogenesis, CANCERS, VOL.12(7)(2020), MDPI, 2020.07.01
• ​The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression, CANCER RESEARCH, VOL.80(11)(2020), AMER ASSOC CANCER RESEARCH, 2020.06.01
• ​Critical roles of ARHGAP36 as a signal transduction mediator of Shh pathway in lateral motor columnar specification, ELIFE, VOL.8(0)(2019), ELIFE SCIENCES PUBLICATIONS LTD, 2019.07.01
• Protective Effects of Nargenicin A1 against Tacrolimus-Induced Oxidative Stress in Hirame Natural Embryo Cells, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, VOL.16(6)(2019), MDPI, 2019.03.22

◆ Patent

• 인진쑥 수용성 추출물, 그 용도 및 제조 방법, 2020.08.28
• 마이크로 RNA를 유효성분으로 함유하는 Ninj1 억제용 시약조성물(Reagent composition for inhibiting Ninj1 comprising microRNA), 2020.03.25
• 후코이단을 포함하는 수면장애 예방, 개선 또는 치료용 조성물, 2020.01.30
• 인진쑥 추출물을 포함하는 수면장애 예방, 개선 또는 치료용 조성물, 2020.01.29
• ​신규한 이소나이트라민 화합물 및 이를 포함하는 대사성 질환 예방 또는 치료용 조성물(Novel Isonitramine Compound and Composition for Preventing or Treating Metabolic Disease Comprising the Same), 2020.01.21​